2 massive drugmakers are locked in a battle over the market for cancer immunotherapy — Goldman analysts say one is pulling ahead

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

Pharma giants Merck and Bristol-Myers Squibb are fighting for dominance in the multi-billion dollar cancer immunotherapy market.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

Behind pay wall.. nice trick

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 729. in SA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and moreDrugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

Pharma Industry Pushes Back Against Required Listing of Drug Prices in TV AdsThe pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support. JUST MAKE IT LAW, THEY HAVE THE MONEY. What could be wrong with this? Pharma, why are you upset with telling consumers how much you are going to cost? Is it that you are worried that we will be pissed off with price gouging like the Epi-pen CEO did? Truth in advertising, what a concept!
مصدر: WSJ - 🏆 98. / 63 اقرأ أكثر »